Test Price
2,800 AED✅ Home Collection Available
EIF2AK3 Gene (Wolcott‑Rallison Syndrome) Genetic Test | AED 2,800 | DNA Labs UAE
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing.
✅ Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection – Available daily from 8 AM to 11 PM.
✅ Clinical Guidance: Complimentary telephonic post‑test clinical guidance for result interpretation.
✅ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This EIF2AK3 gene test detects pathogenic variants causing Wolcott‑Rallison syndrome, a rare autosomal recessive disorder marked by neonatal diabetes, epiphyseal dysplasia, and hepatic dysfunction. Our NGS‑based analysis provides comprehensive coverage of coding regions with 99.9% sensitivity, enabling definitive diagnosis and family risk assessment.
| Feature | Our EIF2AK3 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity / >100× coverage | ~95% sensitivity, variable coverage |
| Method | Next‑Generation Sequencing (NGS) – LC‑MS/MS verified | Conventional Sanger sequencing |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Price (AED) | 2,800 | Not routinely offered |
Physician Insight & Safety Protocols
“As a clinical geneticist, I understand the profound implications of a genetic diagnosis for Wolcott‑Rallison syndrome. This test provides definitive molecular confirmation, but results must be correlated with clinical findings and a pedigree analysis. I strongly advise consulting a genetic counselor to discuss inheritance patterns and family planning options.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Pre‑Test Preparation
✅ Mandatory genetic counseling session – A detailed clinical history and pedigree chart of family members affected by EIF2AK3‑related conditions must be completed before sample collection.
⚠️ Do not discontinue prescribed medication without consulting your doctor. If you are on insulin or other diabetes therapies, continue as directed.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Inability to provide informed consent; minors without guardian consent (per UAE Medical Liability Law); patients with known confounding somatic mosaicism.
- ER Red Flags: Acute metabolic decompensation, severe hypoglycemia, or signs of liver failure – seek immediate emergency care; do not delay for genetic testing.
Patient FAQ & Clinical Guidance
1. What is the purpose of the EIF2AK3 gene test?
This test identifies pathogenic variants in the EIF2AK3 gene to confirm a diagnosis of Wolcott‑Rallison syndrome and inform family planning and management of diabetes, skeletal, and hepatic complications.
2. How is the sample collected?
A single blood draw (whole blood, EDTA tube) or an extracted DNA sample is sufficient. VIP Mobile Phlebotomy and temperature‑controlled home collection are available daily from 8 AM to 11 PM.
3. What does a positive result mean for me or my child?
A positive result confirms the genetic cause of symptoms, enabling precise management of diabetes, skeletal dysplasia, and hepatic dysfunction. It also allows for informed family planning and risk assessment for future pregnancies.
UAE Regulatory & Data Privacy Adherence
This test is conducted in full compliance with UAE data protection and health information security frameworks, including:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing all personal and genetic data processing.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health data management.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – governing clinical safety, informed consent, and patient rights.
All genetic information is handled under strict DHA‑mandated confidentiality protocols and ISO‑accredited laboratory standards.
Clinical & Logistical Metadata
| Test Name | EIF2AK3 Gene (Wolcott‑Rallison Syndrome) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or extracted genomic DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – LC‑MS/MS verified |
| ICD-10-CM Code | Q87.1 |
| LOINC Code | 48020-7 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians